Table 2 |
||||||||||||
|
Pre trial and during trial chlamydia testing numbers, percentages and positivity rates, by control (n = 23) and intervention (n = 20) groups |
||||||||||||
|
Pre-trial period |
Trial period |
|||||||||||
|
|
||||||||||||
|
Women consulted N |
Women tested N (%) |
Positive women N (%) |
Women consulted N |
Women tested N (%) |
Positive women N (%) |
Women tested* P value |
Positive women** P value |
|||||
|
|
||||||||||||
|
Control 16-24 yrs |
2689 |
168 |
(6.2) |
16 |
(9.5) |
1792 |
157 |
(8.8) |
15 |
(9.6) |
p<0.01 |
p = 0.99 |
|
Intervention 16-24 yrs |
2662 |
305 |
(11.5) |
28 |
(9.2) |
1589 |
213 |
(13.4) |
7 |
(3.3) |
p = 0.06 |
p = 0.01 |
|
|
||||||||||||
|
* The difference in proportion of the number of women tested for chlamydia in the pre-trial and trial periods. ** The difference in proportion of the number of women who tested positive for chlamydia in the pre-trial and trial periods. |
||||||||||||
|
Bilardi et al. BMC Public Health 2010 10:70 doi:10.1186/1471-2458-10-70 |
||||||||||||